DOXEPIN Drug Patent Profile

Name: DOXEPIN Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Doxepin, and what generic alternatives are available?

Doxepin is a drug marketed by Adaptis, Aiping Pharm Inc, Ajanta Pharma Ltd, Alembic, Amneal Pharms Co, Appco, Aurobindo Pharma Ltd, Chartwell Rx, Dava Pharms Inc, Epic Pharma Llc, Ixora Lifescience, Jubilant Cadista, Lannett Co Inc, Mankind Pharma, Micro Labs, MSN, Mylan Pharms Inc, New River, Ph Health, Purepac Pharm, Quantum Pharmics, Sandoz, Sun Pharm Industries, Taro, Unique, Velzen Pharma Pvt, Watson Labs, Watson Labs Teva, Zydus Lifesciences, Pharm Assoc, Pharmobedient Cnsltg, Teva Pharms, Amneal, Sun Pharma Canada, Actavis Elizabeth, Rk Pharma, and Strides Pharma Intl. and is included in seventy-nine NDAs.

The generic ingredient in DOXEPIN is doxepin hydrochloride. There are seven drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the doxepin hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Doxepin

A generic version of DOXEPIN was approved as doxepin hydrochloride by MYLAN PHARMS INC on May 13^th, 1986.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for DOXEPIN?
What are the global sales for DOXEPIN?
What is Average Wholesale Price for DOXEPIN?

Summary for DOXEPIN

US Patents:	0
Applicants:	37
NDAs:	79
Drug Prices:	Drug price information for DOXEPIN
Drug Sales Revenues:	Drug sales revenues for DOXEPIN
DailyMed Link:	DOXEPIN at DailyMed

Drug patent expirations by year for DOXEPIN

US Patents and Regulatory Information for DOXEPIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Micro Labs	DOXEPIN HYDROCHLORIDE	doxepin hydrochloride	CAPSULE;ORAL	217688-005	Jun 27, 2023	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Quantum Pharmics	DOXEPIN HYDROCHLORIDE	doxepin hydrochloride	CAPSULE;ORAL	070972-001	Sep 29, 1987		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Dava Pharms Inc	DOXEPIN HYDROCHLORIDE	doxepin hydrochloride	CAPSULE;ORAL	071675-001	Jan 5, 1988		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Chartwell Rx	DOXEPIN HYDROCHLORIDE	doxepin hydrochloride	CAPSULE;ORAL	210268-001	Sep 4, 2020	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Zydus Lifesciences	DOXEPIN HYDROCHLORIDE	doxepin hydrochloride	TABLET;ORAL	202761-001	Aug 16, 2023	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Aurobindo Pharma Ltd	DOXEPIN HYDROCHLORIDE	doxepin hydrochloride	TABLET;ORAL	216041-001	Jul 25, 2024	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for DOXEPIN

Doxepin hydrochloride prices?
Doxepin was originally marketed as an antidepressant?

AI Deep Research

Questions you can ask:

Summary for DOXEPIN

DrugChatter Q&A for DOXEPIN

Make Better Decisions: Try a trial or see plans & pricing